We plan to rapidly advance to a Phase 3 clinical trial in China, bringing us a step closer to a potential new oral treatment option for people living with obesity. In addition to Hengruis plans to advance oral ribupatide to a phase 3 clinical trial for the treatment of obesity in China, Kailera plans to initiate a global phase 2 clinical trial in 2026
These two compounds support fat loss, muscle growth, and improve recovery
10.1016/j.ijscr.2024.109931 9 CaballeroM.LukawskaJ.LeeT.DuguP
Will I need to take a pill or give myself an injection for each dose of this medication
Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before they are marketed
Reassessing your food choices , increasing protein intake to preserve lean mass, and tracking calories for a few weeks can reveal hidden reasons for the stall